Company Insight

Australia’s biggest week in medtech: Showcasing Australia’s medical technology capabilities

The mining sector is notorious for being slow when it comes to embracing new technology.

Main image credit: AusBiotech

Discover Australia’s medtech strengths, successes, and solutions during Australia’s ‘biggest week in medtech’, 20-24 May 2024. Join industry leaders, healthcare professionals, and tech enthusiasts as they converge to progress the development of innovative health breakthroughs with high impact by registering for AusMedtech 2024 and AusMedtechInvest 2024.

Australia’s world-class medical technology industry

Australia has long been a known leader for innovation, especially when it comes to the medical technology sector. Globally recognised for its ground-breaking research & development and strong biotech innovation ecosystem, Australian medtech companies have created solutions that have advanced the quality of healthcare, improved patient outcomes, and ultimately saved lives across the world. From the bionic eye to the electronic pacemaker and spray-on artificial skin, Australia’s medtech industry punches above its weight and is today the largest sector within Australia’s life sciences industry. 

Australia’s life science ecosystem has experienced strong growth over the past five years. As revealed in AusBiotech-commissioned research, the sector is rapidly expanding, with 50 percent growth between 2019 and 2022, for the first time exceeding the number of therapeutic companies developing life-enhancing and life-saving technologies in Australia.  

Australia is a favourable destination for life science companies due to its world-class healthcare and medical research infrastructure, clinical trial timelines, an attractive R&D tax rebate, diverse patient populations, strong IP protection, internationally-recognised regulatory standards and harmonisation with other world-leading regulators, non-partisan government support and investment, and a quality education system with a high number of PhD students. 

Professor Caroline McMillen, Chief Scientist for South Australia, The Hon. Stephen Dawson MLC, Minister for Emergency Services, Innovation and the Digital Economy, Science and Medical Research, Western Australia; and Lorraine Chiroiu, former CEO, AusBiotech

AusMedtech 2024

AusBiotech is creating another immersive experience this year at AusMedtech 2024, where industry pioneers, healthcare professionals, and technology enthusiasts gather to delve into the latest innovations shaping the future of healthcare. From thought-provoking discussions to invaluable networking and 1:1 business matching opportunities, AusMedtech 2024 is Australia’s largest medical technology conference and promises to continue being the cornerstone event of Australia’s biggest week in medtech.

What to expect

Join our thriving network of over 400 industry leaders at AusMedtech 2024 in Adelaide, South Australia where innovation, collaboration and synergy drive success in Australia’s medtech sector. 

A must-attend event if you’re a medtech executive, decision-maker or investor looking to tap into the industry’s strengths, talent, and ingenuity. The streamlined two-day programme includes: 

Cutting-edge insights: Building upon the success of previous years, AusMedtech 2024 offers a dynamic programme featuring 70+ thought-provoking keynotes and expert talks led by industry leaders. Explore a diverse range of topics, including Australian success stories, manufacturing, overcoming distribution challenges, advancements in diagnostics, and emerging technologies from Australia’s innovators.  

Networking opportunities: Engage with industry leaders and potential partners through our exclusive AusPartnering business matching app. AusMedtech provides an ideal platform to exchange ideas, foster collaborations, and connect with like-minded professionals passionate about driving innovation in healthcare. Take advantage of the networking functions including the Welcome Reception, AusMedtech Conference Dinner, Closing Reception, and catering breaks in the Exhibition Hall. 

Inspiring keynotes: Be inspired by our lineup of keynote speakers as they share fresh insights into the latest advancements shaping the future of healthcare technology.  

Interactive panels: Participate in 25+ interactive panel discussions addressing key topics such as fostering innovation, the role of incubators and accelerators in medtech, waste and sustainability, and navigating regulatory and reimbursement landscapes. Learn from experts who have successfully navigated the intricacies of the industry.

Early-Stage Innovation Forum: Discover and support early-stage innovators with presentations from Australia's local research institutes, universities, hospitals, and pre-series A companies on emerging early-stage technologies, as they gather feedback from experts to support their commercialisation journey.

Clinical Trials Dinner: Join industry peers for an informal dinner to celebrate the progress of the clinical trials sector and connect face-to-face before the official start of AusMedtech 2024.

Site tours: Explore South Australia's vibrant life sciences ecosystem, and check out Australia’s world-class infrastructure for free with tours of Adelaide BioMed City, Lot Fourteen, Tonsley Innovation District, Mawson Lakes, and the Australian National Fabrication Facility – South Australia.

Register now to secure your spot at AusMedtech 2024. Check out the AusMedtech 2023 photo galley here.

AusMedtechInvest 2024

AusMedtechInvest 2024 is Australia’s inaugural boutique medtech investment roundtable forum, aiming to build meaningful personal connections between innovative medical technology (devices and diagnostic) businesses and investors to help great ideas attract the capital needed to thrive in a fast-paced, competitive market. 

Investors: Are you looking for the next big breakthrough and are curious about medical innovation down under? Qualified investors are invited to apply for a complimentary pass to Australia’s newest medtech investment event. 

Held during Australia’s biggest week in medtech, join us at the Adelaide Convention Centre on Tuesday 21 May for an intimate half-day programme of company presentations, keynote speakers, and informative market updates along with the opportunity of one-to-one investment partnering.  

At AusMedtechInvest 2024, you’ll hear from Australian CEOs, Managing Directors and founders directly as they showcase their companies and invite you to join them in developing devices, diagnostics, and digital innovations that improve the quality of healthcare. Access industry experts and mingle with other like-minded investors on the hunt for the next great investment opportunity in a world-renowned life sciences destination. 

Qualified investors will also receive discounted registration to AusMedtech 2024, including a free pass to Day One of AusMedtech 2024 to attend the Early-Stage Innovation Forum rapid-fire pitch competition.

Event Details

AusMedtechInvest 2024: 21 May 2024 

AusMedtech 2024: 22 - 23 May 2024 

Location: Adelaide Convention Centre, Adelaide, South Australia 

Registrations now open at and

About AusBiotech

For almost 40 years, AusBiotech has been at the forefront of Australia’s life sciences industry, championing the growth and prosperity of the sector. Representing a diverse network of over 3,000 members spanning therapeutics, medical technology, digital health, and agri-biotech, AusBiotech is committed to promoting the global advancement of Australian life sciences.

Contact information

Level 33, 477 Collins Street, Melbourne VIC 3000

Tel: +61 491 909 710


Phillip Day. Credit: Scotgold Resources

In early June 2019, mining companies avoided increases to royalties by agreeing to provide A$70m to a A$100m infrastructure fund.

Frank Smith, Founder and CEO of TowHaul

  1. Biffa internal savings data, average saving (January - August 2023)
  2. Nisbets internal savings data, average saving (January – September 2023)
  3. Compliance365 internal data, average  savings
  4. HEINEKEN UK data, Calculations based on SmartDispense® active accounts each year since 2015 with 10 lines
  5. Independent test results based on subterranean and ground floor pub cellars of varying sizes
  6. Independent test results based on subterranean and ground floor pub cellars of varying sizes

With diesel vehicles accounting for 30% to 50% of greenhouse emissions at a mine site, replacing them with a battery-electric fleet is a sure way to drastically reduce overall CO2 emissions, but how else can mines benefit from this technology?

Leading underground manufacturers Normet believe the answer lies with SmartDrive. This architecture for battery electric vehicles (BEV) was developed in collaboration with customers, building on feedback, predicting future trends, and assessing the limitations of diesel engines, and comes with a wealth of benefits for operators.